Autus Asset Management’s Pfizer PFE Stock Holding History

Autus Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$219K	Buy	+4,266	New	+$205K	0.04%	142
2022 Q3	–	Sell	-4,322	Closed	-$226K	–	144
2022 Q2	$226K	Buy	4,322 +269	+7%	+$13.7K	0.04%	138
2022 Q1	$209K	Sell	4,053 -364	-8%	-$18.9K	0.03%	151
2021 Q4	$261K	Buy	+4,417	New	+$219K	0.03%	163
2018 Q1	–	Sell	-7,594	Closed	-$261K	–	152
2017 Q4	$261K	Sell	7,594 -37	-0.5%	-$1.26K	0.05%	137
2017 Q3	$258K	Buy	7,631 +589	+8%	+$18.9K	0.05%	140
2017 Q2	$225K	Buy	7,042 +82	+1%	+$2.59K	0.05%	142
2017 Q1	$226K	Sell	6,960 -637	-8%	-$20.1K	0.05%	146
2016 Q4	$234K	Sell	7,597 -554	-7%	-$16.9K	0.05%	138
2016 Q3	$262K	Sell	8,151 -191	-2%	-$6.39K	0.06%	139
2016 Q2	$279K	Buy	8,342 +476	+6%	+$15.2K	0.06%	137
2016 Q1	$222K	Sell	7,866 -1,304	-14%	-$37.2K	0.05%	147
2015 Q4	$281K	Buy	9,170 +269	+3%	+$8.46K	0.07%	141
2015 Q3	$265K	Sell	8,901 -14	-0.2%	-$449	0.08%	113
2015 Q2	$283K	Buy	8,915 +1,550	+21%	+$50.5K	0.08%	117
2015 Q1	$243K	Sell	7,365 -591	-7%	-$18.8K	0.07%	123
2014 Q4	$235K	Sell	7,956 -1,343	-14%	-$38.5K	0.07%	112
2014 Q3	$261K	Sell	9,299 -64	-0.7%	-$1.8K	0.09%	106
2014 Q2	$264K	Buy	9,363 +1,371	+17%	+$39.1K	0.09%	107
2014 Q1	$244K	Sell	7,992 -875	-10%	-$26.1K	0.09%	105
2013 Q4	$258K	Sell	8,867 -411	-4%	-$12K	0.1%	101
2013 Q3	$253K	Sell	9,278 -193	-2%	-$5.25K	0.11%	103
2013 Q2	$252K	Buy	+9,471	New	+$262K	0.11%	103

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Autus Asset Management's PFE Position: Q4 2022 in Review

Autus Asset Management opened a new position in Pfizer (PFE) in Q4 2022: 4,266 shares worth $219K. The stake represents 0.04% of the portfolio and ranks #142 among its holdings. This is a return to the name: Autus Asset Management previously reported a position in PFE as recently as Q2 2022.

Autus Asset Management first reported a position in PFE in Q2 2013 and has held it in 23 quarters since. The position peaked at $283K in Q2 2015. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Autus Asset Management held 4,266 shares of Pfizer worth $219K as of Q4 2022.
Pfizer was a new Autus Asset Management position in Q4 2022.
Pfizer made up 0.04% of Autus Asset Management's portfolio in Q4 2022, its #142 holding.
Autus Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 23 quarters since.
Autus Asset Management's Pfizer position peaked at $283K in Q2 2015.
3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Autus Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.